Tradestie Institutional Equity Comparison Engine

NTLA vs BEAM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BEAM Overall Edge

BEAM Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Beam Therapeutics Inc. Common Stock (BEAM) driven by superior Growth & Margin, Options & Structure while NTLA counters with relative strength in Momentum & Technical. Fundamentally, NTLA trades at N/M Forward P/E with -826.0% operating margin (-48.0% YoY revenue) versus BEAM at N/M Forward P/E and -267.7% operating margin (-96.8% YoY). In options structure, NTLA sits in BREAKDOWN (78th %ile IV; Dealer Gamma Walls on Pro) against BEAM sits in BREAKDOWN (42nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
NTLA N/M vs BEAM N/M Fwd P/E
Growth & Margin Winner BEAM
Op Margin -826.0% vs -267.7% ยท YoY -48.0% vs -96.8%
Momentum & Technical Winner NTLA
1Y +15.3% vs -1.7% ยท 52W Pos 20% vs 6%
Options & Structure Winner BEAM
BREAKDOWN (78th %ile IV) vs BREAKDOWN (42nd %ile IV)
NTLA NASDAQ
Intellia Therapeutics, Inc
In Vitro & In Vivo Diagnostic Substances
$10.00
+3.09% 1D
Market Cap $1.5B
1M Return -12.43%
1Y Return +15.34%
Forward P/E N/M
Unified AI Score
49.9 / 100 HOLD
Tech 47.0 Fund 55.0 Flow 59.0 Mom 60.0
BEAM NASDAQ
Beam Therapeutics Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$21.29
-6.75% 1D
Market Cap $2.4B
1M Return -9.29%
1Y Return -1.71%
Forward P/E N/M
Unified AI Score
45.9 / 100 HOLD
Tech 30.0 Fund 52.0 Flow 70.0 Mom 70.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NTLA +15.34% BEAM -1.71% Spread: +17.05 pp (NTLA Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period NTLA Revenue BEAM Revenue NTLA Op. Margin BEAM Op. Margin Margin Edge
FY2018 $30M N/A -298.6% N/A NTLA
FY2019 $40M $0M -246.8% -417522.2% NTLA
FY2020 $60M $0M -235.5% -553166.7% NTLA
FY2021 $30M $50M -810.4% -757.0% BEAM
FY2022 $50M $60M -879.0% -555.6% BEAM
FY2023 $40M $380M -1420.5% -46.7% BEAM
FY2024 $60M $60M -923.1% -654.3% BEAM
FY2025 $70M $140M -651.7% -274.6% BEAM

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NTLA (4) vs BEAM (4)
Institutional Metric NTLA BEAM Criterion Row Winner
Market Capitalization Scale $1.5B $2.4B Larger Scale BEAM
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -48.0% -96.8% Higher Growth NTLA
Operating Margin (TTM) Profitability -826.0% -267.7% Higher Margin BEAM
Net Profit Margin Profitability 0.0% -73.9% Higher Margin NTLA
Return on Equity (ROE) Capital Efficiency -62.6% -11.3% Higher ROE BEAM
52-Week Range Position Momentum 20% ($8โ€“$18) 6% ($20โ€“$38) Stronger Trend NTLA
Beta / 30D Volatility Risk Regime 2.30ฮฒ ยท 87% Vol 2.24ฮฒ ยท 86% Vol Lower Realized Risk BEAM
Unified Institutional Score Composite Signal 49.9 / 100 (HOLD) 45.9 / 100 (HOLD) Higher Composite NTLA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NTLA vs BEAM Buy Guide
NTLA BREAKDOWN
94d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 78th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live NTLA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BEAM BREAKDOWN
103d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 42nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live BEAM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NTLA nor BEAM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.